ACTRN12612001121853
Recruiting
未知
Development, validation of a new quality of life assessment tool in type 2 diabetes and cross-sectional study to assess the quality of life among diabetics in Malaysia
Dr.Shereen Goh Giap Kah0 sites600 target enrollmentOctober 19, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr.Shereen Goh Giap Kah
- Enrollment
- 600
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects diagnosed with Type 2 diabetes, with or without pharmacological treatment.
- •Subjects above the age of 18 and below the age of 80\.
- •Subjects whom have completed secondary education (12 years of formal education) so as to be able to understand the contents of the questionnaire
- •Subjects who are able to give written consent.
Exclusion Criteria
- •Subjects with concurrent Parkinson’s disease, Alzheimer’s disease, dementia, severe visual impairment.
- •Subjects less than 18 years of age or more than 80 years of age.
- •Subjects whom have not completed 12 years of formal education.
- •Subjects with mental illness impairing judgment who will be unable to give valid consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Quality of life questionnaire related to symptoms of gastroesophageal reflux disease.Gastroesophageal reflux23996RBR-9bb2fpnFaculdade de Medicina de Ribeirão Preto - Universidade de São Paulo
Active, not recruiting
Not Applicable
The development of a quality of life instrument specific to autoimmune bullous diseaseQuality of life in Autoimmune bullous diseaseSkin - Dermatological conditionsPublic Health - Other public healthACTRN12612000750886Australasian Blistering Diseases Foundation70
Completed
Not Applicable
The development of a quality of life instrument specific to treatment effects in autoimmune bullous diseaseQuality of Life in Autoimmune Bullous DiseaseSkin - Dermatological conditionsInflammatory and Immune System - Autoimmune diseasesACTRN12613000365763Australasian Blistering Diseases Foundation70
Not yet recruiting
Phase 1
Study for the improvement of the quality of life of severe patients of novel coronavirus pneumonia (COVID-19) by the integrated Chinese medicine and Western medicine therapyovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003362Guangzhou Women and Children's Medical Center
Completed
Not Applicable
Quality of Life in Neuromuscular DiseaseQuality of LifeMuscular DystrophiesNCT02895763CHU de Reims159